Home
>
National Drug Code (NDC)
>
ATryn
ATryn - 42976-121-02 - (Antithrombin (Recombinant))
Drug Information of ATryn
| Product NDC: | 42976-121 |
| Proprietary Name: | ATryn |
| Non Proprietary Name: | Antithrombin (Recombinant) |
| Active Ingredient(s): | 1750 [iU]/1 & nbsp; Antithrombin (Recombinant) |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of ATryn
| Product NDC: | 42976-121 |
| Labeler Name: | GTC Biotherapeutics, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | BLA125284 |
| Marketing Category: | BLA |
| Start Marketing Date: | 20090506 |
Package Information of ATryn
| Package NDC: | 42976-121-02 |
| Package Description: | 1 VIAL in 1 CARTON (42976-121-02) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL |
NDC Information of ATryn
| NDC Code | 42976-121-02 |
| Proprietary Name | ATryn |
| Package Description | 1 VIAL in 1 CARTON (42976-121-02) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL |
| Product NDC | 42976-121 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Antithrombin (Recombinant) |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20090506 |
| Marketing Category Name | BLA |
| Labeler Name | GTC Biotherapeutics, Inc. |
| Substance Name | ANTITHROMBIN ALFA |
| Strength Number | 1750 |
| Strength Unit | [iU]/1 |
| Pharmaceutical Classes | Recombinant Antithrombin [EPC],Decreased Coagulation Factor Activity [PE],Thrombin Inhibitors [MoA],Factor Xa Inhibitors [MoA] |
